Bioavailability of ATI-1501 With Taste Test Sub Study
Status:
Completed
Trial end date:
2017-12-30
Target enrollment:
Participant gender:
Summary
Appili Therapeutics Inc. is developing an oral suspension formulation of metronidazole
(ATI-1501), a taste-masked reformulation of metronidazole. The purpose of this study is to
compare the relative bioavailability of ATI-1501 with the Reference Listed Drug (RLD) in
healthy, adult volunteers to determine that it is Bioequivalent.